U.S. health officials have approved a groundbreaking pancreatic cancer drug that offers a new approach to treating the deadly form of cancer, by blocking a protein that fuels tumor growth in the vast majority of cases.
Market Samachar is a news aggregator. This article was originally published by NPR. Tap the button above to read the full story on their site.